GASTROESOPHAGEAL CANCER
Clinical trials for GASTROESOPHAGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL CANCER trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Does adding radiation before surgery help stomach cancer patients live longer?
Disease control CompletedThis study looked at whether adding radiation therapy to chemotherapy before surgery could help people with advanced stomach or gastroesophageal junction cancer live longer without the cancer coming back. It involved 204 adults who were healthy enough for surgery. The goal was to…
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: PHASE3 • Sponsor: Shanghai Cancer Hospital, China • Aim: Disease control
Last updated May 26, 2026 03:14 UTC
-
New drug cocktail shows promise for tough stomach cancers
Disease control CompletedThis study tested a combination of drugs (camrelizumab, chemotherapy, and apatinib) as a first treatment for people with advanced stomach or gastroesophageal junction cancer that cannot be removed by surgery. The goal was to see if this combo helps people live longer compared to …
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
New cocktail of chemo and radiation shows promise for tough cancer
Disease control CompletedThis early study tested a powerful mix of chemotherapy drugs (FOLFIRINOX) along with radiation before surgery for people with gastroesophageal junction cancer. The goal was to see if patients could complete the full treatment plan. 25 adults took part, and researchers tracked sid…
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New drug combo shows promise for hard-to-treat cancers
Disease control CompletedThis early-phase study tested a drug called gevokizumab alongside standard cancer treatments in 167 adults with advanced colorectal, stomach, or kidney cancer. The goal was to find a safe dose and see if the combination helps control tumor growth. While not a cure, it aims to imp…
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
Scientists hunt for immunotherapy clues in surgical drain fluid
Knowledge-focused CompletedThis study collected fluid from surgical drains and blood samples from 10 patients who had surgery for stomach or esophageal cancer. Researchers used lab tests to look for molecular markers that might help predict how well a patient will respond to immunotherapy. The goal was to …
Matched conditions: GASTROESOPHAGEAL CANCER
Sponsor: Inova Health Care Services • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC